Sectors

Bitmain and DRW subsidiary Cumberland Mining are set to exit the crypto finance software provider five years after their investment.

Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.

Talaris has raised $150m in an initial public offering almost two decades after being spun out of University of Louisville as Regenerx.

Hella and Susquehanna International Group both took part in a series B round that increased the radar technology developer's overall funding to $75m.

Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.

UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.

Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.

A decade or more after setting up the golden age of corporate venturing units were set up with a focus on life sciences and healthcare, such as US-listed conglomerate Alphabet’s GV (formerly known as Google Ventures) and US-listed drugs company Merck’s Global Health Innovation Fund (GHIF), and the returns have surpassed many expectations.

BitFury is set to exit the crypto wallet developer through a cash-and-stock acquisition by another investor, Galaxy Digital Holdings.

The Coinbase, Ripple and Monex-backed Latin American crypto trading platform was valued at $2.2bn in a round co-led by Tiger Global Management and Coatue Management.

The corporate-backed lidar technology provider will now be valued at $1.52bn pre-acquisition rather than the $1.9bn figure when the deal was announced in February.